National Centre for
Pharmacoeconomics
NCPE Ireland
About Us
Current Staff
News
Glossary
Contact Us
Vacancies
Home
Submission Process
HTA Guidelines
Process Flowchart
Submission Templates
Pharmacoeconomic Evaluations
Drugs
Vaccines
Diagnostics and Other Technologies
Publications
Peer Reviewed Papers
Abstracts
Reports
Research
Pharmacoeconomic Research
Education
COVID-19
For Patients
Drugs
:
V
A
B
C
D
E
F
G
H
I
K
L
M
N
O
P
R
S
T
U
V
Z
Vandetanib (Caprelsa®)
Vedolizumab (Entyvio®) HTA ID: 20029
Vedolizumab (Entyvio®) HTA ID: 20030
Vedolizumab (Entyvio®) in Crohn’s Disease
Vedolizumab (Entyvio®) in Ulcerative Colitis
Velaglucerase Alfa (VPRIV®)
Vemurafenib (Zelboraf®)
Venetoclax (Venclyxto®)
Venetoclax (Venclyxto®) for Acute Myeloid Leukaemia. HTA ID: 22001
Venetoclax (Venclyxto®) in combination with obinutuzumab (Gazyvaro®). HTA ID: 20046
1
2
Next Page
health check